| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018372 |
| Receipt No. | R000021272 |
| Official scientific title of the study | A pilot study to explore the efficacy and safety of jam oral immunotherapy with hypoallergenized cow's milk for children with cow's milk allergy |
| Date of disclosure of the study information | 2015/07/24 |
| Last modified on | 2017/01/25 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A pilot study to explore the efficacy and safety of jam oral immunotherapy with hypoallergenized cow's milk for children with cow's milk allergy | |
| Title of the study (Brief title) | A pilot study for the effect of jam oral immunotherapy with hypoallergenized cow's milk (JMIT study) | |
| Region |
|
|
| Condition | |||
| Condition | food allergy (cow's milk) | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of oral imunotherapy with hypoallergenized cow's milk |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | The threshold change of double blind placebo controlled oral food challenge test |
| Key secondary outcomes | 1. Effectiveness
Change of specific IgE and IgG4 level for cow's milk, casein, B-lactoglobulin 2. Safety a. The proportion of the patients who experienced allergic reactions within 2 hours after the ingestion of the hypoallergenized milk b. The frequency of allergic reactions within 2 hours after the ingestion of the hypoallergenized milk 3. Edibility of jam containing hypoallergenized cow's milk 4. QOL assessment by the parents and of the parents |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Slow oral immunotherapy with hypoallergenized cow's milk for 6 months | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with cow's milk allergy
2. Patients who failed to increase the threshold through conventional slow oral immunotherapy with cow's milk continued for more than six months 3. Patients whose cow's milk-specific IgE level was greater than 15 UA/ml within 8 weeks before registration 4. Patients diagnosed as cow's milk allergy by double blind placebo controlled food challenge test 5. Patients who can keep complete elimination of cow's milk from their diet 6. Patients whose family are cooperative enough to adhere to the protocol of this study |
|||
| Key exclusion criteria | 1. Patients with non-immediate reaction to cow's milk
2. Patients with uncontrolled asthma, atopic dermatitis or urticaria 3. Patients with pineapple or soy allergy 4. Patients who have treatment history or plan with omalizumab 5. Patients who were undergoing oral immunotherapy of build-up phase for other food antigen |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Yukihiro Ohya |
| Organization | National Center for Child Health and Development |
| Division name | Division of Allergy |
| Address | 2-10-1 Okura Setagaya-ku Tokyo, 157-8535 Japan |
| TEL | 03-3416-0181 |
| ohya-y@ncchd.go.jp | |
| Public contact | |
| Name of contact person | Miyuki Hashimoto |
| Organization | National Center for Child Health and Development |
| Division name | Division of Allergy |
| Address | 2-10-1 Okura Setagaya-ku Tokyo, 157-8535 Japan |
| TEL | 03-3416-0181 |
| Homepage URL | |
| hashimoto-my@ncchd.go.jp | |
| Sponsor | |
| Institute | National Center for Child Health and Development |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grant from the National Center for Child Health and Development |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Sagami Women's Junior College Department of Food and Nutrition Science |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021272 |